0001628280-22-028462.txt : 20221104
0001628280-22-028462.hdr.sgml : 20221104
20221104161811
ACCESSION NUMBER: 0001628280-22-028462
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221103
FILED AS OF DATE: 20221104
DATE AS OF CHANGE: 20221104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baldry Mark
CENTRAL INDEX KEY: 0001644137
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38295
FILM NUMBER: 221362578
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS
STREET 2: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: X4 Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0001501697
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273181608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
BUSINESS PHONE: 857-529-8300
MAIL ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
FORMER COMPANY:
FORMER CONFORMED NAME: Arsanis, Inc.
DATE OF NAME CHANGE: 20100920
4
1
wf-form4_166759306432055.xml
FORM 4
X0306
4
2022-11-03
0
0001501697
X4 Pharmaceuticals, Inc
XFOR
0001644137
Baldry Mark
C/O X4 PHARMACEUTICALS INC.
61 NORTH BEACON STREET 4TH FLOOR
BOSTON
MA
02134
0
1
0
0
Chief Commercial Officer
Stock Option (right to buy)
1.89
2022-11-03
4
A
0
341000
1.89
A
2032-11-03
Common Stock
341000.0
341000
D
25% of the shares subject to the option shall vest on November 3, 2023, with the remainder vesting in equal installments of 2.0833% of the shares subject to the option each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date.
/s/ Adam S. Mostafa, attorney-in-fact
2022-11-04